The level of HMGB1 expression was reported to be associated with lymph-node metastasis and advanced TNM stage in esophageal cancer, gastric cancer, colorectal cancer, head and neck cancer, and cervical cancer [29–33]. Here, HMGB1 is linked to metastatic malignant neoplasm in the lymph nodes.